CA2197050A1 - Agents anticancereux issus d'oeufs en coquille fecondes incubes - Google Patents

Agents anticancereux issus d'oeufs en coquille fecondes incubes

Info

Publication number
CA2197050A1
CA2197050A1 CA 2197050 CA2197050A CA2197050A1 CA 2197050 A1 CA2197050 A1 CA 2197050A1 CA 2197050 CA2197050 CA 2197050 CA 2197050 A CA2197050 A CA 2197050A CA 2197050 A1 CA2197050 A1 CA 2197050A1
Authority
CA
Canada
Prior art keywords
egg
fertilized
incubated
composition
eggs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2197050
Other languages
English (en)
Inventor
Morton P. Shulman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MPS Corp
Original Assignee
MPS Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MPS Corp filed Critical MPS Corp
Priority to CA 2197050 priority Critical patent/CA2197050A1/fr
Publication of CA2197050A1 publication Critical patent/CA2197050A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA 2197050 1997-02-07 1997-02-07 Agents anticancereux issus d'oeufs en coquille fecondes incubes Abandoned CA2197050A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2197050 CA2197050A1 (fr) 1997-02-07 1997-02-07 Agents anticancereux issus d'oeufs en coquille fecondes incubes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2197050 CA2197050A1 (fr) 1997-02-07 1997-02-07 Agents anticancereux issus d'oeufs en coquille fecondes incubes

Publications (1)

Publication Number Publication Date
CA2197050A1 true CA2197050A1 (fr) 1998-08-07

Family

ID=4159872

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2197050 Abandoned CA2197050A1 (fr) 1997-02-07 1997-02-07 Agents anticancereux issus d'oeufs en coquille fecondes incubes

Country Status (1)

Country Link
CA (1) CA2197050A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2073822A1 (fr) * 2006-10-12 2009-07-01 United Paragon Associates Inc. Procédés de préparation de constituants d'oeufs fertilisés
WO2009115429A1 (fr) * 2008-03-19 2009-09-24 Joan Cunill Aixela Préparation alimentaire et composition pharmaceutique contenant un extrait embryonnaire
WO2013053503A1 (fr) 2011-10-13 2013-04-18 Cunill Aixela Juan Préparation à base d'œufs à propriétés régénérantes, analgésiques et/ou anti-inflammatoires
US9999654B2 (en) 2012-09-19 2018-06-19 Sc Hipocrate 2002 Serv Srl Composition with increased bioavailability of orally administered embryo-peptides and process for its obtainment
EP3771345A1 (fr) * 2019-07-29 2021-02-03 HatchTech Group B.V. Utilisation de viande d'embryon de poulet

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2073822A1 (fr) * 2006-10-12 2009-07-01 United Paragon Associates Inc. Procédés de préparation de constituants d'oeufs fertilisés
EP2073822A4 (fr) * 2006-10-12 2010-04-14 United Paragon Associates Inc Procédés de préparation de constituants d'oeufs fertilisés
AU2007312906B2 (en) * 2006-10-12 2013-06-27 United Paragon Associates Inc. Processes for preparing fertilized egg components
WO2009115429A1 (fr) * 2008-03-19 2009-09-24 Joan Cunill Aixela Préparation alimentaire et composition pharmaceutique contenant un extrait embryonnaire
ES2337537A1 (es) * 2008-03-19 2010-04-26 Joan Cunill Aixela Preparado alimenticio y composicion farmaceutica que contiene un extracto embrionario y sus respectivos usos.
WO2013053503A1 (fr) 2011-10-13 2013-04-18 Cunill Aixela Juan Préparation à base d'œufs à propriétés régénérantes, analgésiques et/ou anti-inflammatoires
AU2012323427B2 (en) * 2011-10-13 2015-08-27 Ovivity Group S.L. Egg preparation with regenerating, analgesic and/or anti-inflammatory properties
RU2585049C2 (ru) * 2011-10-13 2016-05-27 Овивити Груп, С.Л. Препарат из яиц с регенерирующими, анальгезирующими и противовоспалительными свойствами
US9717764B2 (en) 2011-10-13 2017-08-01 Ovivity Group, S.L. Egg preparation with regenerating, analgesic and/or anti-inflammatory properties
US9999654B2 (en) 2012-09-19 2018-06-19 Sc Hipocrate 2002 Serv Srl Composition with increased bioavailability of orally administered embryo-peptides and process for its obtainment
EP3771345A1 (fr) * 2019-07-29 2021-02-03 HatchTech Group B.V. Utilisation de viande d'embryon de poulet
NL2023582B1 (en) * 2019-07-29 2021-02-22 Hatchtech Group Bv Use of chicken embryo meat

Similar Documents

Publication Publication Date Title
KR100277095B1 (ko) 테스토스테론증강용조성물및그제조방법
ES2312430T3 (es) Composicion normalizadora del ritmo circadiano.
JP4653400B2 (ja) 糖尿病用組成物
US20120021088A1 (en) Oral use
KR20100015595A (ko) 하이드록시타이로솔 및 이를 함유하는 올리브 추출물/농축물의 신규한 용도
JPWO2008069276A1 (ja) 癌治療剤および発癌抑制剤
TWI239245B (en) Medical composition for oral administration or intravenous administration for a disease requiring enhancement of nerve growth factor production for treatment or prevention
AU2022242810A1 (en) Paraxanthine-based compositions for promoting weight loss
WO2018039755A1 (fr) Formulation pharmaceutique à base de zinc et de quercétine pour la production d'un médicament antiviral efficace contre la dengue et zika
ES2808626T3 (es) Composición para la utilización de cinamaldehído y zinc para gestionar el peso
CA2197050A1 (fr) Agents anticancereux issus d'oeufs en coquille fecondes incubes
WO2012116992A2 (fr) Utilisation orale
JP2014148479A (ja) ガレート型カテキンとタンパク質との複合体およびカフェインを含む抗肥満組成物
JP2011116670A (ja) マラリア、ねむり病、エイズ、ｃ型肝炎を撲滅する方法、及びその装置
WO2004045605A1 (fr) Utilisation de flavonoide pour le traitement de la surcharge ponderale et la reduction de l'appetit chez un mammifere
JP2004242663A (ja) ダイエット食品
JP2002187846A (ja) 組成物及びそれを含有する食品、抗関節炎剤、抗リュウマチ剤又は飼料
JP2012024016A (ja) マラリア、ねむり病、エイズ、ｃ型肝炎を撲滅する方法、及びその装置
JP6112767B2 (ja) 血液中の尿酸値を低下させるための組成物
JP2011012021A (ja) 血糖コントロール用組成物
KR20080090101A (ko) 해조식품 매생이를 이용한 건강기능성 식품 및 그의제조방법
WO2018101231A1 (fr) Composition permettant l'activation du nerf sympathique
KR20190086871A (ko) 피조개 추출물을 유효성분으로 함유하는 알코올성 간 손상 억제용 조성물
JP2012170435A (ja) マラリア、ねむり病、エイズ、ｃ型肝炎を撲滅する方法、及びその装置
KR100729847B1 (ko) 쓴 맛이 차폐된 글루콘산아연 경구투여용 제제 조성물

Legal Events

Date Code Title Description
FZDE Dead